Key facts
- Goatherapeutics’s last known valuation is $150.0M (Dec 2024).
- It has raised $31.1M; the latest was Seed Round ($31.0M) in Dec 2024.
- Notable investors include KittyHawk, Lauder Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Goatherapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Goatherapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Goatherapeutics
Operator of a therapeutics company intended to address various health conditions. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Santa Monica, CA, United States
- Founded
- 2024
- Website
- goatherapeutics.com/
- Ownership
- Privately Held (backing)
Goatherapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Goatherapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Goatherapeutics in its N-PORT filings yet. We sweep new filings monthly.